Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194225 | SCV000248505 | uncertain significance | not specified | 2014-12-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000899471 | SCV001043742 | likely benign | Pyruvate dehydrogenase E1-alpha deficiency | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381655 | SCV002689325 | likely benign | Inborn genetic diseases | 2017-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001833137 | SCV002076939 | likely benign | Pyruvate dehydrogenase complex deficiency | 2019-10-28 | no assertion criteria provided | clinical testing |